VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 117 filers reported holding VERONA PHARMA PLC in Q4 2023. The put-call ratio across all filers is 2.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,860 | +49.7% | 1,166 | +66.6% | 0.00% | – |
| Q1 2024 | $11,263 | -87.4% | 700 | -84.4% | 0.00% | -100.0% |
| Q4 2023 | $89,360 | +1181.0% | 4,495 | +950.2% | 0.00% | – |
| Q3 2023 | $6,976 | -89.5% | 428 | -86.4% | 0.00% | -100.0% |
| Q2 2023 | $66,337 | +72797.8% | 3,138 | -30.8% | 0.00% | -33.3% |
| Q1 2023 | $91 | +378.9% | 4,534 | +520.2% | 0.00% | +200.0% |
| Q4 2022 | $19 | -99.7% | 731 | +32.2% | 0.00% | – |
| Q3 2022 | $6,000 | -25.0% | 553 | -74.0% | 0.00% | – |
| Q2 2022 | $8,000 | +60.0% | 2,126 | +106.2% | 0.00% | – |
| Q1 2022 | $5,000 | +150.0% | 1,031 | +209.6% | 0.00% | – |
| Q4 2021 | $2,000 | -80.0% | 333 | -81.3% | 0.00% | – |
| Q3 2021 | $10,000 | +11.1% | 1,777 | +30.2% | 0.00% | – |
| Q2 2021 | $9,000 | +800.0% | 1,365 | +582.5% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 200 | -23.7% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 262 | -28.4% | 0.00% | – |
| Q1 2019 | $2,000 | -50.0% | 366 | -17.2% | 0.00% | – |
| Q4 2018 | $4,000 | +33.3% | 442 | +73.3% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 255 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -66.7% | 255 | -45.7% | 0.00% | -100.0% |
| Q1 2018 | $9,000 | +200.0% | 470 | +136.2% | 0.00% | – |
| Q3 2017 | $3,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,369,000 | $47,095,720 | 7.54% |
| NEA Management Company, LLC | 5,108,563 | $111,024,890 | 7.40% |
| Vivo Capital, LLC | 4,249,918 | $84,488,370 | 6.92% |
| Aisling Capital Management LP | 1,115,352 | $22,173,198 | 6.61% |
| Rosalind Advisors, Inc. | 250,000 | $4,970,000 | 4.09% |
| First Turn Management, LLC | 1,206,291 | $23,981,065 | 3.44% |
| Knoll Capital Management, LLC | 200,000 | $3,976,000 | 3.29% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $59,925,258 | 3.20% |
| Tri Locum Partners LP | 293,112 | $5,827,067 | 2.66% |
| Carlyle Group Inc. | 2,457,500 | $48,805,950 | 2.35% |